… of these events. We describe the main results of the Sleep Apnea Cardiovascular Endpoints
… of CPAP in reducing the rate of cardiovascular events among patients with obstructive sleep …

… -analysis to evaluate the risk of mortality and cardiovascular events for OSA patients
treated with CPAP. We also assessed the effect of CPAP on the Epworth sleepiness score (ESS), …

… on the efficacy of CPAP as an intervention to prevent cardiovascular events in patients with
… , is CPAP therapy more effective for the reduction of major adverse cardiovascular events (…

… association between OSAS and cardiovascular events in patients with concomitant cardio-metabolic
diseases and the potential impact of CPAP therapy on cardiovascular outcomes. …

… duration of CPAP adherence was only … CPAP may not be adequate to prevent cardiovascular
events. In a prespecified propensityscore–matched analysis, 561 patients who used CPAP …

… other cardiovascular events (… CPAP reduces the risk of fatal and nonfatal CVE in severe
OSA [9]. Furthermore, we have previously published a 5-yr follow-up study showing that CPAP …

… CPAP for prevention of cardiovascular events in obstructive sleep apnea.  … of CPAP on
the prevention of cardiovascular events in OSA. All 3 studies involved exploring the effect of …

… The SAVE trial suggested that CPAP therapy failed to reduce CV events with a mean CPAP
usage time of 3.3 h/night [hazard ratio (HR) 1.10, 95% confidence interval (CI) 0.91–1.32; P …

… CPAP is an effective therapy for subjective sleepiness in those with OSA [23]. Observational
studies show lower cardiovascular events and mortality with the use of CPAP therapy; …

… Considering the conflicting previous evidence, we aimed to assess the effect of long-term
CPAP treatment on major CV events in real-world OSA patients in a population-based …